IL15 and neoplasm: Separately, subcutaneous delivery of cationic liposomes containing an IL-15-encoding plasmid as an adjuvant, paired with an autologous whole-cell tumor vaccine, achieved substantial tumor growth suppression in mice without adverse effects.